X-15822833-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_005089.4(ZRSR2):āc.1040A>Gā(p.Tyr347Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000413 in 1,211,105 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000089 ( 0 hom., 1 hem., cov: 24)
Exomes š: 0.0000036 ( 0 hom. 2 hem. )
Consequence
ZRSR2
NM_005089.4 missense
NM_005089.4 missense
Scores
1
6
10
Clinical Significance
Conservation
PhyloP100: 7.27
Genes affected
ZRSR2 (HGNC:23019): (zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2) This gene encodes an essential splicing factor. The encoded protein associates with the U2 auxiliary factor heterodimer, which is required for the recognition of a functional 3' splice site in pre-mRNA splicing, and may play a role in network interactions during spliceosome assembly. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.33867168).
BS2
High Hemizygotes in GnomAdExome4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZRSR2 | NM_005089.4 | c.1040A>G | p.Tyr347Cys | missense_variant | 11/11 | ENST00000307771.8 | NP_005080.1 | |
ZRSR2 | XM_011545589.4 | c.1109A>G | p.Tyr370Cys | missense_variant | 10/10 | XP_011543891.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZRSR2 | ENST00000307771.8 | c.1040A>G | p.Tyr347Cys | missense_variant | 11/11 | 1 | NM_005089.4 | ENSP00000303015.7 | ||
ZRSR2 | ENST00000684799.1 | c.962A>G | p.Tyr321Cys | missense_variant | 10/11 | ENSP00000510773.1 | ||||
ZRSR2 | ENST00000690252.1 | n.1040A>G | non_coding_transcript_exon_variant | 11/13 | ENSP00000510140.1 | |||||
ZRSR2 | ENST00000691502.1 | n.938-12A>G | intron_variant | ENSP00000509336.1 |
Frequencies
GnomAD3 genomes AF: 0.00000887 AC: 1AN: 112786Hom.: 0 Cov.: 24 AF XY: 0.0000286 AC XY: 1AN XY: 34928
GnomAD3 genomes
AF:
AC:
1
AN:
112786
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
34928
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000218 AC: 4AN: 183523Hom.: 0 AF XY: 0.0000442 AC XY: 3AN XY: 67949
GnomAD3 exomes
AF:
AC:
4
AN:
183523
Hom.:
AF XY:
AC XY:
3
AN XY:
67949
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000364 AC: 4AN: 1098266Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 2AN XY: 363620
GnomAD4 exome
AF:
AC:
4
AN:
1098266
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
363620
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000886 AC: 1AN: 112839Hom.: 0 Cov.: 24 AF XY: 0.0000286 AC XY: 1AN XY: 34991
GnomAD4 genome
AF:
AC:
1
AN:
112839
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
34991
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 15, 2024 | The c.1040A>G (p.Y347C) alteration is located in exon 11 (coding exon 11) of the ZRSR2 gene. This alteration results from a A to G substitution at nucleotide position 1040, causing the tyrosine (Y) at amino acid position 347 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
PrimateAI
Benign
T
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Gain of catalytic residue at L348 (P = 0.0125);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at